A Bayesian analysis of the influence of GSTT1 polymorphism on the cancer risk estimate for dichloromethane

Toxicology and Applied Pharmacology

Volumn 174, Issue 2, 2001, Pages 99-112

  Jonsson, Fredrik ^a   Johanson, Gunnar ^a,b  

^a NATIONAL INSTITUTE FOR WORKING LIFE   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bayesian analysis; Dichloromethane; Markov chain Monte Carlo simulation; Methylene chloride; PBPK; Physiologically based modeling; Risk assessment; Uncertainty; Variability

Indexed keywords

DICHLOROMETHANE; METHYL CHLORIDE;

ARTICLE; BAYES THEOREM; CANCER RISK; ENZYME POLYMORPHISM; GENE FREQUENCY; LONG TERM EXPOSURE; MODEL; POPULATION; RISK ASSESSMENT; SIMULATION; SWEDEN; SYSTEM ANALYSIS; TOXICOKINETICS;

EID: 0035878822     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2001.9206     Document Type: Article

References (48)

1. Metabolism of dihalomethanes to formaldehyde and inorganic halide. 1. In vitro studies
2. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans
3. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride
4. Effect of physical exercise on uptake, distribution and elimination of vapors in man
5. Exposure to methylene chloride I. Its concentration in alveolar air and blood at rest and exercise and its metabolism
6. Statistical issues in toxicokinetic modeling: A Bayesian perspective
7. Reaction of rat liver glutathione S-transferases and bacterial dichloromethane dehalogenase with dihalomethanes
8. Interindividual differences in the in vitro conjugation of methylene chloride with glutathione by cytosolic glutathione S-transferase in 22 human liver samples
9. Analysis of PBPK models for risk characterization
10. MCSim: A Monte Carlo Simulation Program
11. Concordance between enzyme activity and genotype of glutathione S-transferase theta (GSTT1)
12. Adipose tissue blood flow during prolonged exercise II. Pflügers Arch
13. Methylene chloride: A two-year inhalation toxicity and oncogenicity study in rats and hamsters
14. Does the duration of anesthetic administration affect the pharmacokinetics or metabolism of inhaled anesthetics in humans?
15. Dichloromethane metabolism to formaldehyde and reaction of formaldehyde with nucleic acids in hepatocytes of rodents and humans with and without glutathione S-transferase T1 and M1 genes
16. 1 mice but not Syrian golden hamsters exposed to dichloromethane: Pharmacokinetics and risk assessment with DPX as dosimeter
17. Tissue weights and rates of blood flow in man for predictions of anaesthetic uptake and distribution
18. The impact of exercise and intersubject variability on dose estimates for dichloromethane derived from a physiologically based pharmacokinetic model
19. Quantification of biological variability
20. Variability in biological monitoring of solvent exposure. I Development of a population physiological model
21. Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans
22. Exposure to methylene chloride: Content in subcutaneous adipose tissue
23. Density of body fat in man and other animals
24. Inhalation anesthesia using physiologically based pharmacokinetic models
25. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues
26. Inference from iterative simulation using multiple sequences (with discussion)
27. Spreadsheet programming - A new approach in physiologically based modeling of solvent toxicokinetics
28. Physiologically based pharmacokinetic modeling of inhalation exposure of humans to dichloromethane during moderate to heavy exercise
29. Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene
30. The body composition profile. Techniques of measurement and applications
31. Metabolism of dihalomethanes to carbon monoxide. II. In vitro studies
32. Glutathione transferase T1 phenotype affects the toxicokinetics of inhaled methyl chloride in human volunteers
33. Inhalation toxicology and carcinogenesis studies of methylene chloride (dichloromethane) in F344/N rats and B6C3F1 mice
34. Influence of cytochrome P-450 inhibitors on the inhalative uptake of methyl chloride and methylene chloride in male B6C3F1 mice
35. Variability of safe dose estimates when using complicated models of the carcinogenic process
36. In vitro metabolism of methylene chloride in human and animal tissues: Use in physiologically based pharmacokinetic models
37. Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic model for methylene chloride: Implications for risk assessment
38. Human variability and noncancer risk assessment - An analysis of the default uncertainty factor
39. Bayesian computational methods
40. Comparison of GST theta activity in liver and kidney of four species
41. Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation
42. Polymorphic distribution of glutathione transferase activity with methyl chloride in human blood
43. Genotypic and phenotypic determination of polymorphic glutathione transferase T1 in a Swedish population
44. Total body water volumes for adult males and females estimated from simple anthropometric measurements
45. Chemical Analyses of the Body
46. Reference values for resting blood flow to organs of man